Stock comparison
United Therapeutics
Veeva Systems
Scored across Buffett, Graham, Lynch and Greenblatt - plus a side-by-side metric table covering valuation, quality, growth and balance sheet.
UTHR
United Therapeutics
Market cap
$24.13B
Sector
Healthcare
VEEV
Veeva Systems
Market cap
$26.07B
Sector
Healthcare
Overall winner
Veeva Systems VEEV
Wins on the combined sum of fit scores across all four strategies. Per-strategy breakdown below.
Fit scores by strategy
| Strategy | UTHR | VEEV | Winner |
|---|---|---|---|
| Warren Buffett | 71B | 66B | UTHR |
| Benjamin Graham | 76B | 81A | VEEV |
| Philip Fisher | 76B | 77B | VEEV |
| Peter Lynch | 62C | 60C | UTHR |
| Joel Greenblatt | 46D | 52C | VEEV |
| Charlie Munger | 64C | 62C | UTHR |
| Terry Smith | 64C | 65D | VEEV |
Side-by-side metrics
| Metric | UTHR | VEEV |
|---|---|---|
| Market cap | $24.13B | $26.07B |
| P/E (TTM) | 19.2x | 28.7x |
| EV/EBIT | 15.2x | 26.9x |
| ROIC (TTM) | 18.81% | 9.48% |
| Gross margin | 86.58% | 75.53% |
| Net margin | 40.61% | 28.44% |
| Revenue CAGR 5y | 17.22% | 14.63% |
| EPS CAGR 5y | 29.84% | 18.76% |
| Debt / Equity | - | 0.0x |
| Dividend yield | 0.0% | 0.0% |
Where each one wins
The metrics with the biggest gap between the two - sorted so the most decisive edges read first.
UTHR leads on
- Debt / Equity-vs 0.0x+100%
- ROIC (TTM)18.81%vs 9.48%+50%
- EV/EBIT15.2xvs 26.9x+43%
- EPS CAGR 5y29.84%vs 18.76%+37%
VEEV leads on
- Market cap$26.07Bvs $24.13B+7%
Related on invest-like
Key terms in this analysis
Educational tool. Fit scores are deterministic projections from public financials onto each investor's published criteria - not personal recommendations or advice.